Letermovir conversion after valganciclovir treatment in cytomegalovirus high‐risk abdominal solid organ transplant recipients may promote development of cytomegalovirus‐specific cell mediated immunity. - Jorgenson, Margaret R; Kleiboeker, Hanna; Garg, Neetika; Parajuli, Sandesh; Mandelbrot, Didier A; Odorico, Jon S; Saddler, Christopher M; Smith, Jeannina A (Transplant Infectious Disease, 2022)